GlucoTrack, Inc.
NASDAQ Capital MarketTotal Valuation
GlucoTrack, Inc. carries a market capitalization of 578,654.00, placing it among publicly traded companies globally. Its enterprise value stands at 32.25M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 578,654.00 |
| Enterprise Value | 32.25M |
Share Statistics
GlucoTrack, Inc. currently has 6.56M shares outstanding.
| Shares Outstanding | 6.56M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | -18.05 |
| P/TBV Ratio | -18.05 |
| P/FCF Ratio | -0.75 |
| P/OCF Ratio | -0.74 |
Financial Position
GlucoTrack, Inc. maintains a current ratio of 0.46, meaning it holds 0.5x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.46 |
| Quick Ratio | 0.38 |
| Debt / Equity | -112.52 |
| Debt / EBITDA | -0.13 |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -272.48 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
GlucoTrack, Inc.'s stock has declined approximately -99.30053% over the past 52 weeks. The 50-day moving average sits at 3.09, while the 200-day moving average is 14.51.
| Beta (5Y) | N/A |
| 52-Week Price Change | -99.30053% |
| 50-Day Moving Average | 3.09 |
| 200-Day Moving Average | 14.51 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -15.33M, while operating income came in at -15.40M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -15.40M |
| Pretax Income | -15.95M |
| Net Income | -15.95M |
| EBITDA | -15.33M |
| EBIT | -15.40M |
| Earnings Per Share (EPS) | -6.34 |
Balance Sheet
GlucoTrack, Inc. holds 1.12M in cash and equivalents against 1.96M in total debt, resulting in a net debt position of 816,000.00. Total book value stands at -1.74M, with working capital of -1.61M providing operational flexibility.
| Cash & Cash Equivalents | 1.12M |
| Total Debt | 1.96M |
| Net Debt | 816,000.00 |
| Equity (Book Value) | -1.74M |
| Book Value Per Share | -0.27 |
| Working Capital | -1.61M |
Cash Flow
GlucoTrack, Inc. produced -16.22M in operating cash flow over the past twelve months. After subtracting -87,000.00 in capital expenditures, free cash flow totaled -16.31M - equivalent to -6.48 per share.
| Operating Cash Flow | -16.22M |
| Capital Expenditures | -87,000.00 |
| Free Cash Flow | -16.31M |
| FCF Per Share | -6.48 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -25.09 |
| FCF Yield | -133.90 |
Stock Splits
GlucoTrack, Inc.'s most recent stock split took place on August 31, 2026 with a 15:1 split ratio.
| Last Split Date | 8/31/2026 |
| Split Ratio | 15:1 |
Scores
GlucoTrack, Inc. posts an Altman Z-Score of -179.28, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -179.28 |